FI962120L - Estramustiiniformulaatiot, joilla on parannetut farmaseuttiset ominaisuudet - Google Patents

Estramustiiniformulaatiot, joilla on parannetut farmaseuttiset ominaisuudet Download PDF

Info

Publication number
FI962120L
FI962120L FI962120A FI962120A FI962120L FI 962120 L FI962120 L FI 962120L FI 962120 A FI962120 A FI 962120A FI 962120 A FI962120 A FI 962120A FI 962120 L FI962120 L FI 962120L
Authority
FI
Finland
Prior art keywords
estramustine
formulations
pharmaceutical properties
improved pharmaceutical
improved
Prior art date
Application number
FI962120A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI962120A0 (fi
FI962120A7 (fi
Inventor
Alessandro Martini
Giuseppe Maccari
Lorena Muggetti
Giuseppe Colombo
Giovanni Buzzi
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Publication of FI962120L publication Critical patent/FI962120L/fi
Publication of FI962120A0 publication Critical patent/FI962120A0/fi
Publication of FI962120A7 publication Critical patent/FI962120A7/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/661Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI962120A 1994-09-22 1995-09-01 Estramustiiniformulaatiot, joilla on parannetut farmaseuttiset ominais uudet FI962120A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9419153A GB9419153D0 (en) 1994-09-22 1994-09-22 Estramustine formulations with improved pharmaceutical properties
PCT/EP1995/003438 WO1996009072A1 (en) 1994-09-22 1995-09-01 Estramustine formulations with improved pharmaceutical properties

Publications (3)

Publication Number Publication Date
FI962120L true FI962120L (fi) 1996-05-20
FI962120A0 FI962120A0 (fi) 1996-05-20
FI962120A7 FI962120A7 (fi) 1996-05-20

Family

ID=10761769

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962120A FI962120A7 (fi) 1994-09-22 1995-09-01 Estramustiiniformulaatiot, joilla on parannetut farmaseuttiset ominais uudet

Country Status (27)

Country Link
US (1) US5712260A (cs)
EP (1) EP0730474B1 (cs)
JP (1) JP3568957B2 (cs)
KR (1) KR960705587A (cs)
CN (1) CN1135719A (cs)
AT (1) ATE219378T1 (cs)
AU (1) AU698425B2 (cs)
CA (1) CA2174968A1 (cs)
CZ (1) CZ292125B6 (cs)
DE (1) DE69527129T2 (cs)
DK (1) DK0730474T3 (cs)
ES (1) ES2179115T3 (cs)
FI (1) FI962120A7 (cs)
GB (1) GB9419153D0 (cs)
HU (1) HUT75935A (cs)
IL (1) IL115376A (cs)
MX (1) MX9601852A (cs)
MY (1) MY115689A (cs)
NO (1) NO314438B1 (cs)
NZ (1) NZ292895A (cs)
PL (1) PL183132B1 (cs)
PT (1) PT730474E (cs)
RU (1) RU2179036C2 (cs)
TW (1) TW496739B (cs)
UA (1) UA48126C2 (cs)
WO (1) WO1996009072A1 (cs)
ZA (1) ZA957938B (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9921954D0 (en) * 1999-09-16 1999-11-17 Pharmacia & Upjohn Spa Formulations for parenteral use of estramustine phosphate with improved pharmacological properties
GB9921958D0 (en) 1999-09-16 1999-11-17 Pharmacia & Upjohn Spa Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins
ITMI20031015A1 (it) * 2003-05-20 2004-11-21 Naxospharma S R L Poli-(amminopirrolcarbossammidi) per uso nella profilassi e nel trattamento delle endoparassitosi animali e loro composizioni con ciclodestrine.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3299104A (en) * 1963-04-09 1967-01-17 Leo Ab Certain steroid nu-bis-(haloethyl)-carbamates
JPS6327440A (ja) * 1986-07-18 1988-02-05 Sanraku Inc グルコシル化分岐シクロデキストリン含有組成物
SE8802402D0 (sv) * 1988-06-28 1988-06-28 Pharmacia Ab Novel esters
GB8920135D0 (en) * 1989-09-06 1989-10-18 Erba Carlo Spa Use of dehydrated cyclodextrins for improving drug dissolution
GB9005133D0 (en) * 1990-03-07 1990-05-02 Ellis J C Ltd Crop lifting apparatus
FR2667070A1 (fr) * 1990-09-21 1992-03-27 Besins Iscovesco Labo Sterouides inclus dans des cyclodextrines procede pour leur preparation complexes et formes goleniques correspondants et leurs applications therapeutiques.

Also Published As

Publication number Publication date
JP3568957B2 (ja) 2004-09-22
TW496739B (en) 2002-08-01
NZ292895A (en) 1998-04-27
DE69527129D1 (de) 2002-07-25
PT730474E (pt) 2002-11-29
CZ145696A3 (en) 1996-08-14
UA48126C2 (uk) 2002-08-15
RU2179036C2 (ru) 2002-02-10
IL115376A (en) 1999-05-09
IL115376A0 (en) 1995-12-31
MY115689A (en) 2003-08-30
NO961979D0 (no) 1996-05-14
FI962120A0 (fi) 1996-05-20
EP0730474A1 (en) 1996-09-11
GB9419153D0 (en) 1994-11-09
JPH09505832A (ja) 1997-06-10
FI962120A7 (fi) 1996-05-20
ATE219378T1 (de) 2002-07-15
AU698425B2 (en) 1998-10-29
KR960705587A (ko) 1996-11-08
US5712260A (en) 1998-01-27
DK0730474T3 (da) 2002-09-23
NO314438B1 (no) 2003-03-24
PL183132B1 (pl) 2002-05-31
ES2179115T3 (es) 2003-01-16
AU3519995A (en) 1996-04-09
PL314584A1 (en) 1996-09-16
CA2174968A1 (en) 1996-03-28
HU9601738D0 (en) 1996-08-28
CZ292125B6 (cs) 2003-08-13
NO961979L (no) 1996-05-14
EP0730474B1 (en) 2002-06-19
MX9601852A (es) 1997-03-29
ZA957938B (en) 1996-04-18
HUT75935A (en) 1997-05-28
CN1135719A (zh) 1996-11-13
DE69527129T2 (de) 2003-03-06
WO1996009072A1 (en) 1996-03-28

Similar Documents

Publication Publication Date Title
TR199501420A2 (tr) Acillenmis ensülin benzerleri.
TR199501082A2 (tr) Farmasötik formülasyonlar.
EP0684299A3 (de) Dihydrofarnesal.
FI1592U1 (fi) Spruta, foeretraedesvis injektionsspruta
FI962120L (fi) Estramustiiniformulaatiot, joilla on parannetut farmaseuttiset ominaisuudet
TR28915A (tr) Naftokinon türevleri.
ATE193300T1 (de) 14alpha,17alpha-c2-überbrückte 19-nor- progesteronderivate
ES1029442Y (es) Balaustrada perfeccionada.
FR2714950B3 (fr) Réducteur-variateur.
IT234659Y1 (it) Sottosella.
ES1027963Y (es) Pulsador-interruptor perfeccionado.
ES1028162Y (es) Papelera-cenicero perfeccionada.
ES1032362Y (es) Sobre perfeccionado.
IT1268116B1 (it) Sedia.
ES1031199Y (es) Almohada magneto-terapeutica, perfeccionada.
ES1029264Y (es) Banderola perfeccionada.
ES1029364Y (es) Banderola perfeccionada.
TR199500776A2 (tr) Farmasötik bilesimler.
ES1028108Y (es) Mamposta perfeccionada.
ES1029315Y (es) Estructura de camilla para estetica y medicina, mejorada.
ES1032056Y (es) Almohada perfeccionada.
ES1027192Y (es) Almohada perfeccionada.
ES1027955Y (es) Almohada perfeccionada.
ES1027698Y (es) Almohadon perfeccionado.
ES1026981Y (es) Aspersor-turbina perfeccionado.

Legal Events

Date Code Title Description
MA Patent expired